Tuesday, November 20, 2018

Tomasz Kluszczynski

Senior Principal, IQVIA

Tomasz Kluszczynski
Tomasz Kluszczynski

Tomasz is a Senior Principal at IQVIA Consulting responsible for strategic projects such as Launch Excellence, Market Access & Pricing and Portfolio and Geo Expansion.

Before joining IQVIA, he worked as the Head of Healthcare Practice EMEA for Kaiser Associates in London. Tomasz has worked closely with Global, Regional, and Local Pharma companies, across the US, Europe, Russia and CIS.

He is a frequent Speaker at Global and European Conferences on, amongst others, Biosimilars, Emerging Biopharma and Pricing and Market Access. He is also an author of numerous White Papers and Publications including “Delivering on the Potential of Biosimilar Medicines”.

Tomasz holds MA degree from University of Oxford.

Keynote Speakers

A. John Iafrate Dr. Iafrate is a Professor of Pathology at Harvard Medical School and is Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics and newly appointed Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH).
Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.
Luca Sangiorgi He is Head of Department of Medical Genetics and Coordinator of Rare Disease Centre at Rizzoli Orthopaedic Institute, Bologna, and Contract professor of Clinical Genetics of Bologna University.
  • ORGANIZED BY
  • UNDER THE AUSPICES OF
  • SPONSORS
  • SUPPORTERS
MSD
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • INTERPRETATION SPONSOR
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team